Clinical Risk Score is Superior to Fasting C‐peptide–Based β‐Cell Function Markers in Predicting Insulin Requirement in Individuals With Type 2 Diabetes
Diabetes/Metabolism Research and Reviews · 2026
DOI: 10.1002/dmrr.70126 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes/Metabolism Research and Reviews, 2026. Verfasst von Yingnan Fan und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, People's Republic of China. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, C-Peptide, Insulin-Secreting Cells, Insulin. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Hong Kong Government Health and Medical Research Fund.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Aims
This study aims to evaluate the predictive performance of clinical characteristics and beta‐cell function markers for future insulin requirements in Chinese individuals with type 2 diabetes who were not insulin deficient. Materials and Methods A prospective cohort of 2421 individuals with type 2 diabetes and fasting plasma C‐peptide ≥ 0.25 nmol/L (1996–2012) was followed until 2019 for insulin requirement, defined as insulin initiation or two consecutive HbA1c ≥ 8.5% while on at least two non‐insulin glucose‐lowering drugs. Cox regression with stepwise selection was used to identify predictors and derive a clinical risk score. Model calibration was assessed using the Hosmer‐Lemeshow test, and discrimination using the Harrell's C‐index and area under the receiver operating characteristic curve (AUC) at one, five and 10 years.
Results
Over a median follow‐up of 10.2 (IQR 4.0–14.1) years, 1143 individuals progressed to insulin requirements. Younger age at diabetes diagnosis, male sex, poorer glycaemic control, kidney complications and greater use of non‐insulin glucose‐lowering drugs were identified as independent predictors. The clinical risk score demonstrated better discrimination (C‐index: 0.729, AUCs: 0.829 at 1 year, 0.792 at 5 years, 0.779 at 10 years) than fasting plasma C‐peptide (C‐index: 0.532, AUCs: 0.502, 0.553, 0.537), C‐peptide‐to‐glucose ratio (C‐index: 0.560, AUCs: 0.660, 0.572, 0.571) and HOMA2‐%B (C‐index: 0.618, AUCs: 0.734, 0.651, 0.639) (all p < 0.001). Adding fasting plasma C‐peptide or HOMA2‐%B to the clinical model did not significantly improve its predictive performance.
Conclusions
Clinical characteristics outperformed fasting beta‐cell function markers in predicting insulin requirements in non‐insulin‐deficient type 2 diabetes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, People's Republic of China.
- Hong Kong Institute of Diabetes and Obesity, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, People's Republic of China.
- Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, People's Republic of China.
- Phase 1 Clinical Trial Centre, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, People's Republic of China.
ORCID-Profile: Yingnan Fan
Förderung
- Hong Kong Government Health and Medical Research Fund
Zitieren
APA
Fan, Y., Fan, B., Lau, E. S. H., Lim, C. K. P., Wu, H., Chow, E. W. K., Kong, A. P. S., Chow, E., Ma, R. C. W., Chan, J. C. N., & Luk, A. O. Y. (2026). Clinical Risk Score is Superior to Fasting C‐peptide–Based β‐Cell Function Markers in Predicting Insulin Requirement in Individuals With Type 2 Diabetes. Diabetes/Metabolism Research and Reviews. https://doi.org/10.1002/dmrr.70126
Vancouver
Fan Y, Fan B, Lau ESH, Lim CKP, Wu H, Chow EWK, et al. Clinical Risk Score is Superior to Fasting C‐peptide–Based β‐Cell Function Markers in Predicting Insulin Requirement in Individuals With Type 2 Diabetes. Diabetes/Metabolism Research and Reviews. 2026. doi:10.1002/dmrr.70126
BibTeX
@article{Fan2026,
author = {Fan, Yingnan and Fan, Baoqi and Lau, Eric S H and Lim, Cadmon K P and Wu, Hongjiang and Chow, Edith W K and Kong, Alice P S and Chow, Elaine and Ma, Ronald C W and Chan, Juliana C N and Luk, Andrea O Y},
title = {Clinical Risk Score is Superior to Fasting C‐peptide–Based β‐Cell Function Markers in Predicting Insulin Requirement in Individuals With Type 2 Diabetes},
journal = {Diabetes/Metabolism Research and Reviews},
year = {2026},
doi = {10.1002/dmrr.70126}
}
EUVIMED